Search

Embecta Corp

Open

SectorHealthcare

5.28 1.93

Overview

Share price change

24h

Current

Min

5.08

Max

5.21

Key metrics

By Trading Economics

Income

25M

21M

Sales

50M

272M

P/E

Sector Avg

3.565

56.432

EPS

0.56

Dividend yield

9.31

Profit margin

7.766

Employees

1,850

EBITDA

17M

62M

Dividends

By Acuity

Dividend yield

Sector Avg

9.31%

2.27%

Next Earnings

24 lis 2026

Next Dividend date

17 gru 2026

Next Ex Dividend date

4 gru 2026

Market Stats

By TradingEconomics

Market Cap

76M

297M

Previous open

3.35

Previous close

5.28

News Sentiment

By Acuity

29%

71%

46 / 339 Ranking in Healthcare

Embecta Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

16 wrz 2026, 20:10 UTC

Embecta Corp is advancing amid a positive market environment, though it remains below its 20-day moving average and near the lower end of its one-month range.

15 wrz 2026, 20:07 UTC

News

Embecta Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC, contributing to a decline in shares amid broader market pressures.

14 wrz 2026, 20:04 UTC

Embecta Corp shares are higher today, rebounding from an early dip without specific news to explain the movement. Broader market concerns include rising crude oil prices.

11 wrz 2026, 19:16 UTC

Embecta Corp shares are higher amid U.S. Consumer Price Index data, which showed inflation at 3.4% annually, aligning with forecasts.

10 wrz 2026, 21:31 UTC

Embecta Corp shares are higher in after-market trading, continuing an upward move since Thursday's close, despite being below its 20-day moving average.

9 wrz 2026, 20:02 UTC

Embecta Corp shares are lower today, continuing a decline since Tuesday's close. The stock peaked earlier in the session before reversing sharply.

8 wrz 2026, 20:02 UTC

News

Embecta Corp shares are lower as an investigation raises governance concerns among shareholders. Investors are assessing potential implications of the inquiry.

3 wrz 2026, 19:36 UTC

Embecta Corp shares are higher as market sentiment improves amid easing interest rate concerns and declining Treasury yields.

2 wrz 2026, 23:36 UTC

Embecta Corp. shares are higher in after-market hours, reflecting broader market trends amid ADP's report of weak private sector job growth in August.

1 wrz 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, with no specific news identified to explain the decline amid broader market concerns over rising crude oil prices.

31 sie 2026, 20:07 UTC

Embecta Corp shares are higher today, trading near the upper end of their one-month range and above the 20-day moving average.

28 sie 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, with no specific news identified. The stock has shown strong performance over the past month.

27 sie 2026, 20:07 UTC

Event
News

Bronstein, Gewirtz & Grossman, LLC is investigating Embecta Corp for potential corporate wrongdoing. Shares are trading roughly flat following the company's recent $0.01 dividend.

26 sie 2026, 19:36 UTC

Embecta Corp's shares are lower today, continuing a downward trend since Tuesday. Economic data shows persistent inflation, impacting market sentiment.

25 sie 2026, 19:16 UTC

News

Embecta Corp. shares decline amid an announced investigation into potential corporate wrongdoing by Bronstein, Gewirtz & Grossman, LLC. Shares pulled back from earlier session highs.

24 sie 2026, 20:02 UTC

Embecta Corp's shares are lower amid broader market declines, reflecting ongoing geopolitical concerns. No specific company news was identified to explain the movement.

21 sie 2026, 23:02 UTC

Embecta Corp shares are lower in after-market hours, reflecting a decline since Friday's close amid broader market volatility linked to inflation concerns.

20 sie 2026, 19:41 UTC

Embecta Corp shares are higher during Thursday's session, despite an earlier pullback. No specific news was identified to explain the price movement.

19 sie 2026, 23:01 UTC

Embecta Corp shares are lower in after-market trading, having dipped by as much as -1.85% earlier. No specific news was identified for the movement.

18 sie 2026, 19:16 UTC

Embecta Corp's shares are higher during Tuesday's session, reflecting a modest increase since Monday's close amid rising Treasury yields and inflation concerns.

17 sie 2026, 23:41 UTC

Embecta Corp shares are higher in after-market trading, recovering from a recent low and remaining above their 20-day moving average. No specific news was identified.

15 sie 2026, 00:01 UTC

News

Embecta Corp shares are lower in after-market trading amid two class action lawsuits alleging securities fraud and a significant revenue decline.

14 sie 2026, 23:21 UTC

News

Embecta Corp shares are lower in after-market hours amid negative sentiment from two class action lawsuits alleging securities fraud and disappointing second-quarter guidance.

13 sie 2026, 23:01 UTC

Embecta Corp shares are higher in after-market trading, reflecting strong gains since Thursday's close and trading above its 20-day moving average.

12 sie 2026, 19:02 UTC

News

Embecta Corp shares are trading lower amid a class action lawsuit alleging securities fraud, following a significant revenue decline and ongoing scrutiny of financial performance.

11 sie 2026, 22:01 UTC

Embecta Corp shares are higher in after-market hours, continuing recent gains. The stock remains significantly above its 20-day moving average.

10 sie 2026, 23:21 UTC

News

Embecta Corp shares are lower in after-market trading amid a securities class action reminder regarding alleged misleading fiscal guidance.

7 sie 2026, 23:31 UTC

Embecta Corp is higher in after-market trading, reflecting positive momentum amid broader market strength and significant gains in major tech stocks.

6 sie 2026, 23:42 UTC

Embecta Corp shares are higher in after-market hours, recovering from earlier lows. No specific news was identified to explain this movement.

5 sie 2026, 22:36 UTC

News

Embecta Corp faces a securities fraud class action lawsuit over misleading fiscal statements, contributing to a modest decline in after-market trading.

Peer Comparison

Price change

Embecta Corp Forecast

Rating Consensus

By TipRanks

Sell

1 ratings

0

Buy

0

Hold

1

Sell

Sentiment

By Acuity

46 / 339 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.